| 2022-12-16 | NRx Pharmaceuticals, Inc. NRXP | CHIEF FINANCIAL OFFICER | 30,000 0.0436% | $1.10 | $33,000 | -55.52% | ||
| 2022-11-25 | NRx Pharmaceuticals, Inc. NRXP | CHIEF FINANCIAL OFFICER | 16,337 0.0241% | $1.11 | $18,215 | -49.65% | ||
| 2021-06-15 | PDS Biotechnology Corporation PDSB | 17,647 0.0704% | $8.50 | $150,000 | -2.5% | |||
| 2017-09-12 | Research Frontiers Incorporated REFR | CFO & VP-Buisness Develpoment | 4,000 0.0164% | $1.15 | $4,600 | -16.24% | ||
| 2014-06-19 | Research Frontiers Incorporated REFR | CFO & VP-Business Development | 2,000 0.0085% | $5.45 | $10,900 | -4.32% | ||
| 2011-02-10 | Research Frontiers Incorporated REFR | VicePresident-Business Dev/CFO | 24,000 0.1359% | $8.65 | $207,600 | -50% |